Endothelial adhesion molecules play an important role in the tissue recruitment of leukocytes in inflammatory conditions such as rheumatoid arthritis. We have investigated the effect of the antirheumatic drug gold sodium thiomalate on adhesion molecule protein and mRNA expression in cultured human endothelial cells. Gold sodium thiomalate inhibited cytokine (TNF, IL-1, IL-4)-stimulated expression of vascular cell adhesion molecule-i and E-selectin but not intercellular adhesion molecule-i on endothelial cells. Gold sodium thiomalate also suppressed TNF-stimulated increases in vascular cell adhesion molecule-i and E-selectin mRNA levels but had no effect on intercellular adhesion molecule-i mRNA. Thiomalate (mercaptosuccinate), but not gold thioglucose or D-penicillamine, mimics the effect of gold sodium thiomalate at equimolar concentrations. We propose that the inhibition of vascular cell adhesion molecule-i and E-selectin expression by gold sodium thiomalate is due to its thiomalate and not its gold component. Gold sodium thiomalate has a direct effect on endothelial adhesion molecule expression, and this may contribute to its antiinflammatory activity. (J.
Introduction
Leukocyte infiltration is a key component of chronic inflammation (1) . Adhesion molecules on endothelial cells play an important role in targeting and facilitating leukocyte migration out of the blood vessels, in response to an inflammatory stimulus.
Stimulation of endothelial cells in vitro with inflammatory cytokines such as TNF results in increased expression of inter-molecule-i (VCAM-1), and E-selectin (2, 3) . ICAM-1 is expressed on a wide variety of cell types but only at low levels on unstimulated endothelial cells (4) . TNF or IL-1 stimulation induces increased expression of ICAM-1 that reaches a plateau after 24 h and remains elevated for at least 2 d. VCAM-1 is not constitutively expressed and peaks after 10-24 h of TNF stimulation. E-selectin expression is restricted to endothelial cells (4) . While there is no basal expression of E-selectin on endothelial cells, continuous TNF or IL-1 stimulation results in a maximum level after 6 h which then declines (2, 4) . The transient expression of E-selectin in vitro may not always be relevant in vivo. Sustained in vivo E-selectin expression has been observed in chronically inflamed tissues including psoriatic skin and rheumatoid synovium (5, 6) . Moreover, in vitro and in vivo IFN--y prolongs E-selectin expression. It has been suggested that IFN-y, released at sites of inflammation, may extend the duration of E-selectin expression (7, 8) .
Elevated levels of TNF have been demonstrated in rheumatoid arthritic joints (9, 10) . Increased expression of VCAM-1 (II), E-selectin (6), CD31 (PECAM-1), and /63 integrin subunit (vitronectin receptor) (12) is present on the endothelial cells of rheumatoid synovium compared with normal or osteoarthritic synovium. A number of antiinflammatory drugs have been shown to affect adhesion molecules and/or leukocyte-endothelial interactions (for review see reference 13) . Notably, the expression of ICAM-1 on endothelial cells is reduced by colchicine (14) and dexamethasone (15) . Furthermore, synovial biopsies from rheumatoid patients treated with gold sodium thiomalate (GSTM) show decreased E-selectin expression (16) .
Despite the extensive body of literature on the mechanism by which gold compounds alleviate rheumatoid arthritis (17, 18) , no dominant paradigm has emerged. GSTM inhibits monocyte oxygen radical generation (19) and Fc and C3 receptor expression and chemotaxis (20) . Moreover, GSTM has effects on endothelial cells including inhibition of cell proliferation (21) and HLA-DR expression (22) .
Studies in mice and humans indicate that GSTM readily dissociates in vivo. The gold component rapidly binds to sulfhydryl groups on proteins while free thiomalate (TM) is either rapidly excreted or taken up by tissues. In mice, 6 h after injection, only 0.1% of the thiomalate remains circulating, while 50% is incorporated into tissues (23) . These observations, and the lack of correlation between blood gold concentrations and therapeutic effect, have led to the proposal that TM is responsible for some or all of the antiinflammatory effect of GSTM (24, 25) . In this study, we have investigated the in vitro effect of GSTM and TM on TNF-stimulated expression of ICAM-1, VCAM-1, and E-selectin on endothelial cells.
Methods
Reagents. Bovine lung heparin, BSA, di-sodium EDTA, Tween 20, 2,2'-azino-bis-(3-ethylbenzthiazoline-6-sulfonic acid), and 3,-4,5 dimethyl- Adhesion molecules were detected using ELISA by incubating cells with a primary antibody to either ICAM-1 (1:3,000 ascites), VCAM-1 (0.1 sg/ml), or E-selectin (0.1 sg/ml). In the case of the ICAM-1 assay, cells were incubated with a peroxidase-conjugated goat anti-mouse secondary antibody. VCAM-1 and E-selectin antibodies were detected with the Vectastain ABC kit by incubating the cells with a biotinylated secondary antibody followed by avidin-conjugated peroxidase. Finally, the expression of ICAM-1, VCAM-1, and E-selectin was quantitated by the addition of the peroxidase substrate 2,2'-azino-bis-(3-ethylbenzthiazoline-6-sulfonic acid). The absorbance of each well was measured at 414 nm, and the background at 492 nm was subtracted. Within each experiment, wells containing endothelial cells were treated in quadruplicate with each dose of drug. At each dose, mean±SD was calculated.
Flow cytometry. HUVE cells were plated at confluent density onto 60-cm-diameter cell culture dishes. After overnight incubation, the growth medium was removed and replaced with basal medium with and without TNF and GSTM. After 24 h of incubation, the plates were MTT cell viability assay. HUVE cells were incubated for 24 h with TNF and the highest concentration of each test drug as per cell ELISA. Cells were then washed with PBS and incubated 2-3 h with MITT (0.4 mg/ml) in basal medium (29) . Cells were washed again with PBS, and formazan crystals were dissolved with 100 Il DMSO. The absorbance of each well was measured at 540 nm. The effect of each drug on cell viability was calculated from the means of quadruplicates as follows:
Percent viability = 100 x (Test absorbance/Drug-free absorbance).
Northern blot analysis. were removed using trypsinfEDTA, and total RNA was isolated using a guanidine thiocyanate-phenol-chloroform method based on that of Chomczynski and Sacchi (30) . 15 og of denatured total RNA was electrophoresed through a 1.4% agarose gel containing 1.25 M formaldehyde and then was transferred to GeneScreen nylon membrane and ultraviolet cross-linked (Stratalinker; Stratagene, La Jolla, CA). The replicate treatments were processed independently throughout the RNA isolation and electrophoresis.
DNA probes of VCAM-I, mouse fl-actin, E-selectin, and ICAM- 1 were labeled with [a-32P]dCTP by the random primer method and incorporated at least 109 cpm/pg. The membrane was prehybridized overnight in 5X sodium chloride sodium phosphate EDTA buffer (SSPE) (31), 2% SDS, 10% dextran sulfate, and 1 ,Lg/ml sheared salmon sperm DNA at 650C. The membrane was hybridized overnight with VCAM-1 (> 10 cpm/ml) in the prehybridization solution and was then washed at high stringency in 0.1 X SSPE, 0.1% SDS at 650C. Autoradiography and quantification of band intensities was performed using a Phosphor-Imager (Molecular Dynamics, Inc., Sunnyvale, CA). The same procedure was used to probe with actin, E-selectin, and then ICAM-1. To avoid overlapping bands, the membrane was stripped by boiling in 10 mM Tris, 1 mM EDTA, 1% SDS for a half an hour before probing with E-selectin and ICAM-1. The relative transcript accumulation for a given band was calculated from the ratio of counts in the band to counts in the actin band of that same lane. (32) . A significant slope is evidence that the drug exerts a dose-dependent effect.
Results
The effect of GSTM on the cytokine-stimulated expression of endothelial adhesion molecules was investigated using a cell ELISA (Fig. 1) . Incubation of endothelial cells with TNF for 24 h increased the expression of ICAM-1, VCAM-1, and Eselectin. However, when GSTM was also added, VCAM-1 and E-selectin expression was suppressed in a concentration-dependent manner (Fig. 1) . By contrast, the expression of ICAM-1 remained unaffected. TNF stimulation for 6 h also elevated Eselectin expression but no dose-dependent effect of GSTM was observed over this period (Fig. 1) . The cell ELISA method used to detect E-selectin and VCAM-1 differed slightly from that used for ICAM-1. To exclude this as the explanation for the difference between the effect of GSTM on VCAM-1 compared with ICAM-1, another assay system was evaluated. Flow cytometry was used to compare the effect of GSTM on VCAM-1 and ICAM-1 expression. Fig. 2 illustrates that 1,000 ttM GSTM decreases VCAM-1 expression but not ICAM-1 expression, a finding consistent with the cell ELISA result.
To ascertain whether the effect of GSTM was specific for TNF-activated cells, we investigated the GSTM response of HUVE cells stimulated with IL-I or IL-4. When IL-I was used (in place of TNF) to stimulate adhesion molecule expression, GSTM again exhibited a selective dose-dependent inhibition of VCAM-1 and E-selectin, but not ICAM-1, expression after 24 h (Fig. 3) . Similarly, GSTM inhibited the IL-4-stimulated expression of VCAM-1. IL-4 did not elevate ICAM-1 or E-selectin expression.
To determine which component(s) of GSTM was responsible for the inhibition of VCAM-1 and E-selectin expression, we examined the effect of GTG and TM. Like GSTM, GTG is an antirheumatic gold(I) compound, but the thiol ligand binding the gold is based on glucose rather than malic acid. D-pen was also examined because it is used clinically and like TM has a reduced thiol group. Fig. 4 illustrates that thiomalate exhibited Mean±SD was calculated from four replicate wells. Where SD is not shown, it is less than or equal to the size of the markers. The slope of the linear regression line, based on two independent experiments, was statistically significant when VCAM-I expression was stimulated by TNF (P < 0.005), IL-1 (P < 0.05), or IL-4 (P < 0.005). GSTM also had a significant effect on E-selectin, but not ICAM-1, expression during TNF (P < 0.0005) or IL-I (P < 0.0005) stimulation. IL-4 did not stimulate either ICAM-1 or E-selectin expression. a similar effect to GSTM while D-pen and GTG showed no effect over the range of 1-1,000 MM.
A range of other thiol compounds was studied in an attempt to elucidate the specificity and mechanism of GSTM and TM inhibition of VCAM-I and E-selectin expression. Thiolactate and thioglycolate were chosen as they are structurally related to TM. The possible importance of a reduced thiol group was further investigated using cysteine and cystine. Cysteine has a free SH group, while cystine is composed of two cysteine molecules joined by a disulfide bond. Thioglucose, which is related to GTG, was also evaluated.
Thioglycolate and cysteine had a modest inhibitory effect at high concentrations, while thioglucose had no significant effect on VCAM-I or E-selectin expression (Fig. 5 ). Thiolactate had a slight effect on VCAM-1 but not E-selectin expression. None of these thiol compounds approached the potency of TM in the inhibition of VCAM-1 and E-selectin expression.
The concentration range over which cystine could be studied was limited. Cystine (100 1M) is an ingredient of the basal medium (ICN Biomedicals), and the solubility of cystine (26) limited the maximum useable concentration to 300 MM. HUVE cells incubated for 24 h with TNF and 300 MM cystine displayed significant (P < 0.0001, t test, n = 4) reductions in VCAM-1 (less 14%) and E-selectin (less 16%) expression relative to the basal concentration of 100 MM cystine. The effect of BSO (an inhibitor of glutathione synthesis) was studied to test the hypothesis that glutathione was involved in the inhibition of VCAM-1 and E-selectin expression by GSTM and TM. Over the concentration range of 0.2-200 MM, the slope of the linear regression line, based on three independent experiments, was not significantly different from zero. In a typical experiment, the absorbance due to VCAM-1 expression ranged between 1.11 and 1.12, while the absorbance due to Eselectin ranged from 0.82 to 0.84.
Kinetic studies were undertaken to further evaluate the similarities in the effects of GSTM and TM on endothelial cell adhesion molecule expression. Fig. 6 illustrates the time course for the inhibition of VCAM-1 and E-selectin expression by 30 MM GSTM or TM. In the absence of TNF and GSTM or TM, the background expression of the adhesion molecules remained low. In the presence of TNF alone, VCAM-1 expression reached a plateau at 12 h and remained elevated at 24 h. By contrast, E-selectin expression peaked between 6 and 12 h and then declined. When cells were incubated with TNF and either GSTM or TM, the expression of both VCAM-1 and E-selectin decreased compared with cells treated with TNF alone. This effect was noted at 6 h and became more marked by 12 h. A 51Cr release assay was used to investigate whether GSTM or TM had cytotoxic effects on endothelial cells that could explain the reduction in adhesion molecule expression. There was no significant difference (P = 0.105, ANOVA) in 51Cr release between cells incubated with or without GSTM or TM (Fig. 7 ). An MTT cytotoxicity assay, which relies on the activity of mitochondrial dehydrogenases (29) , recorded a 20% drop in cell viability at 1,000 yM GSTM or TM. 1,000 tzM cysteine and 300 /.M cystine both decreased viability by 10% relative to 0 MM concentrations. None of the other drugs investigated displayed any toxicity in the MTT assay.
Having established that GSTM and TM inhibited the expression of VCAM-1 and E-selectin protein, we investigated their effect on adhesion molecule mRNA levels. Northern blot analysis showed that endothelial cells stimulated with TNF had higher levels of ICAM-1, VCAM-1, and E-selectin mRNA than cells incubated without TNF (Fig. 8) . The presence of 1,000 ,uM GSTM or TM reduced the (TNF-stimulated) levels of VCAM-1 and E-selectin mRNA to near basal levels but had no effect on ICAM-1 transcript. Band intensities were used to quantitate mRNA species relative to the actin band (Fig. 9 ). Fisher's significant difference test (33) established that only at 1,000 /;M GSTM or TM was VCAM-1 mRNA significantly (P < 0.005) reduced relative to the "TNF only" control. 30 MM GSTM or TM had no significant effect (P > 0.05) on VCAM-1 mRNA. In contrast, E-selectin transcript was significantly (P < 0. (Fig. 8) 1) expression on the synovial endothelium of rheumatoid arthritis patients treated with GSTM. However, it is unclear whether this is a direct effect of GSTM on synovial endothelium or an indirect effect by reducing inflammation and cytokine levels. We used an in vitro model to investigate the effect of GSTM on endothelial adhesion molecule expression and found that GSTM exhibited a selective and dose-dependent inhibition of VCAM-1 and E-selectin expression (Fig. 1) . From this we conclude that GSTM can act directly on endothelial cells to inhibit VCAM-1 and E-selectin expression. Cronstein et al. (15) observed that the inhibition of ICAM-1 and E-selectin by dexamethasone occurred with IL-1-and endotoxin-, but not TNF-, stimulated endothelial cells. We found that GSTM inhibited both the TNF-and IL-I -stimulated expression of VCAM-1 and E-selectin (Fig. 3) . GSTM was also effective when IL-4 was used to selectively induce VCAM-1. This suggests that GSTM acts at a step common to the pathways by which these cytokines induce VCAM-1 and E-selectin expression. The effectiveness of GSTM, regardless of cytokine, is consistent with the hypothesis that the inhibition of adhesion molecule expression is a mechanism by which GSTM exerts some of its antiinflammatory properties in vivo.
GSTM dissociates into protein-bound gold and free thiomalate in vivo (23, 24) . It is likely that a similar reaction occurs in vitro. The effect of GSTM on VCAM-1 and E-selectin expression could be due to the gold component, the thiomalate, or both. We demonstrated that TM, without gold, is sufficient to inhibit VCAM-1 and E-selectin expression (Fig. 4) . As GTG showed no effect, we conclude that gold(I) is not required for the inhibition of adhesion molecule expression.
The thiol group is the chemical group that distinguishes GSTM and TM from most other compounds in the cell. To examine the importance of this group in the inhibitory activity of GSTM and TM on adhesion molecule expression, a number of other thiol compounds were tested. Neither D-pen, cysteine, cystine, thioglucose, thiolactate, nor thioglycolate at equimolar concentrations approached the degree of inhibition of VCAM-1 and E-selectin expression that is produced by TM (Fig. 5) . Thus, the mere presence of a thiol moiety per se is unlikely to explain the effect of GSTM and TM.
The observation that thiolactate (CH3CH(SH)COO-) and E-selectin i -tW' (Fig. 7 ). An MTT assay was used as a third independent indicator of cell viability. A small drop in cell viability at 1,000 MM GSTM and TM was noted but is unlikely to account for the marked effect on VCAM-1 and Eselectin expression.
The inhibitory effect of GSTM and TM was further characterized by kinetic studies (Fig. 6) . The time course of TNFstimulated VCAM-1 expression is consistent with previous reports (2, 4) . The effect of GSTM and TM is apparent after 12 h incubation, although there is a small difference in VCAM-1 expression after just 6 h between cells treated with TNF only and those with GSTM. Continuous TNF stimulation induced Eselectin expression to increase rapidly and peak between 6 and 12 h. E-selectin expression decreased to 60% of the peak level by 24 h. The prolonged E-selectin expression observed in our experimental system, compared with others (2), remains unexplained. After 6 h of incubation there is negligible difference between cells treated with and without GSTM despite E-selectin expression being maximal (Fig. 6) . It is only after 12 and 24 h that the difference is evident. This suggests that there is a delay between the addition of GSTM or TM to the cells and the time when these drugs exert their effect. The entry of TM into cells is not rapid. Aguilera et al. (34) found that the intracellular concentration of thiomalate was only 15% of the 30 mM concentration in the medium after 1 h of incubation. When we pretreated endothelial cells by incubating for 24 (24) . A preliminary trial of oral TM for the treatment of rheumatoid arthritis was very encouraging (35) . However, these results have not been published as a complete paper. Furthermore, when the trial was independently repeated, oral TM was found to be ineffective and to cause adverse side effects (36) . No trials involving parenteral administration of TM (analogous to GSTM therapy) have been reported. It may be that the route of delivery, and/or the association with gold, is critical for TM to decrease adhesion molecule expression in vivo.
TM is known to be a potent inhibitor of the enzyme glutathione peroxidase, as is D-pen, in a cell-free system (37) . However, we observed that D-pen did not inhibit the expression of any of the adhesion molecules tested. Thus, assuming D-pen can penetrate the cell membrane to a similar degree as TM, it is unlikely that TM inhibits VCAM-1 expression by blocking glutathione peroxidase. In a further experiment, we evaluated the effect of BSO (an inhibitor of glutathione synthesis) on endothelial adhesion molecule expression. 200 MM BSO eliminates glutathione, the substrate for glutathione peroxidase, after 24 h of incubation (38) . Thus, by eliminating its substrate, the activity of glutathione peroxidase within the cells can be indirectly inhibited. However, we observed that 0.2-200 MM BSO had no effect on VCAM-1 or E-selectin expression on TNF-stimulated endothelial cells. Thus, it is unlikely that the inhibition of VCAM-1 and E-selectin by TM is due to the inhibition of glutathione peroxidase.
A possible mechanism for the inhibition of adhesion molecule expression involves the second messenger cAMP. Elevated cAMP, induced by forskolin or isobutyl methylxanthine, inhibits VCAM-1 and E-selectin but not ICAM-1 expression on TNFstimulated endothelial cells (39) . The similarity of this effect, to that which we observed with GSTM, suggests that GSTM may inhibit adhesion molecule expression by increasing cAMP in endothelial cells. In fact, Scheinberg et al. (20) observed increased cAMP in monocytes incubated in vitro with GSTM and suggested that this may be responsible for inhibited chemotaxis. However, in contrast, Lazarevic et al. (40) observed that GSTM inhibited the activity of adenylate cyclase from lymphocyte membranes. This would result in decreased intracellular cAMP. Thus, to resolve whether or not cAMP is involved in the inhibition of VCAM-1 and E-selectin by GSTM, it would be necessary to determine the effect of GSTM on endothelial cAMP and to correlate this with adhesion molecule expression.
In summary, we have demonstrated that GSTM inhibits the in vitro endothelial expression of VCAM-1 and E-selectin, but not ICAM-1. We propose that this inhibition is due to the thiomalate and not the gold component of GSTM and involves the reduction of mRNA for VCAM-1 and E-selectin. The decrease in endothelial adhesion molecule expression by GSTM may reduce the recruitment of leukocytes to rheumatoid synovium and thus may contribute to the antiinflammatory effects of this compound.
